Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45.

These cases highlight the importance for physicians and health professionals to consider the increasing number of novel, untested recreational drugs, as a potential cause of unusual and otherwise unrecognized clinical signs and symptoms.